Back to GetFilings.com



Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q


(Mark One)

     
x   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended June 27, 2003

OR

     
o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from            to

Commission File Number 000-26519

SEMINIS, INC.

(Exact Name of Registrant as Specified in Its Charter)
     
Delaware
(State or Other Jurisdiction of Incorporation or
Organization)
  36-0769130
(I.R.S. Employer Identification No.)
2700 Camino del Sol, Oxnard, California
(Address of Principal Executive Offices)
  93030-7967
(Zip Code)

(805) 647-1572
(Registrant’s telephone number, including area code)

Not Applicable
(Former name, address and former fiscal year, if changed since last report)

     Indicate, by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. YES x NO o

     Indicate, by check mark whether the Registrant is an accelerated filer (as defined in rule 12b-2 of the Exchange Act). YES o NO x

     As of July 31, 2003, the Registrant had 19,012,719 registered shares of Class A Common Stock, $0.01 par value per share, issued and outstanding and 45,142,508 unregistered shares of Class B Common Stock, $0.01 par value per share, issued and outstanding.



 


TABLE OF CONTENTS

PART I — FINANCIAL INFORMATION
Item 1. Financial Statements
Consolidated Balance Sheets
Consolidated Statements of Operations
Consolidated Statement of Stockholders’ Equity
Consolidated Statements of Cash Flows
Notes to Consolidated Financial Statements
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures
PART II — OTHER INFORMATION
Item 1. Legal Proceedings
Item 6. Exhibits and Reports on Form 8-K
Signatures
Certification
EXHIBIT 99.1
EXHIBIT 99.2


Table of Contents

SEMINIS, INC.

Form 10-Q
For the Quarterly Period Ended June 27, 2003

TABLE OF CONTENTS

         
        Page
    PART I — FINANCIAL INFORMATION    
Item 1.   Financial Statements    
    Consolidated Balance Sheets as of June 27, 2003 and September 30, 2002     3
    Consolidated Statements of Operations for the Three and Nine Months Ended June 27, 2003 and June 28, 2002     4
    Consolidated Statement of Stockholders’ Equity for the Nine Months Ended June 27, 2003     5
    Consolidated Statements of Cash Flows for the Nine Months Ended June 27, 2003 and June 28, 2002     6
    Notes to Consolidated Financial Statements     7
Item 2.   Management’s Discussion and Analysis of Financial    
    Condition and Results of Operations   14
Item 3.   Quantitative and Qualitative Disclosures About Market Risk   21
Item 4.   Controls and Procedures   21
    PART II — OTHER INFORMATION    
Item 1.   Legal Proceedings   22
Item 6.   Exhibits and Reports on Form 8-K   22
    Signatures   25
    Certification of Results   26

2


Table of Contents

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements

SEMINIS, INC.
Consolidated Balance Sheets

(In thousands, except per share data)

                     
                As of
        As of   September 30,
        June 27, 2003   2002
       
 
        (Unaudited)        
Assets:
               
Current assets
               
 
Cash and cash equivalents
  $ 28,130     $ 36,805  
 
Accounts receivable, less allowances for doubtful accounts of $14,154 and $12,344, respectively
    175,269       140,315  
 
Inventories
    266,150       272,527  
 
Prepaid expenses and other current assets
    4,329       2,427  
 
   
     
 
   
Total current assets
    473,878       452,074  
Property, plant and equipment, net
    163,564       168,729  
Goodwill, net
    102,706       98,931  
Intangible assets, net
    54,514       61,872  
Other assets
    20,035       18,391  
 
   
     
 
 
  $ 814,697     $ 799,997  
 
 
   
     
 
Liabilities, Mandatorily Redeemable Stock and Stockholders’ Equity:
               
Current liabilities
               
 
Short-term borrowings
  $ 39,774     $ 28,532  
 
Current maturities of long-term debt
    219,454       21,709  
 
Accounts payable
    22,784       38,179  
 
Accrued liabilities
    97,218       98,624  
 
   
     
 
   
Total current liabilities
    379,230       187,044  
Long-term debt
    14,965       228,293  
Deferred income taxes
    18,740       15,753  
Minority interest in subsidiaries
    1,677       1,902  
 
   
     
 
   
Total liabilities
    414,612       432,992  
 
   
     
 
Commitments and contingencies (see Note 8)
               
Mandatorily redeemable stock
               
 
Class B Redeemable Preferred Stock, $.01 par value; 25 shares authorized as of June 27, 2003 and September 30, 2002; 25 shares issued and outstanding as of June 27, 2003 and September 30, 2002
    31,000       29,500  
 
   
     
 
   
Total mandatorily redeemable stock
    31,000       29,500  
 
   
     
 
Stockholders’ equity
               
 
Class C Preferred Stock, $.01 par value; 17 and 14 shares authorized as of June 27, 2003 and September 30, 2002, respectively; 17 and 12 shares issued and outstanding as of June 27, 2003 and September 30, 2002, respectively (Liquidation Value of $191.9 and $138.2 million at June 27, 2003 and September 30, 2002, respectively)
    1       1  
 
Class A Common Stock, $.01 par value; 211,000 shares authorized as of June 27, 2003 and September 30, 2002; 19,013 and 18,940 shares issued and outstanding as of June 27, 2003 and September 30, 2002, respectively
    190       190  
 
Class B Common Stock, $.01 par value; 67,000 shares authorized as of June 27, 2003 and September 30, 2002; 45,142 shares issued and outstanding as of June 27, 2003 and September 30, 2002
    452       452  
 
Additional paid-in-capital
    697,855       699,255  
 
Accumulated deficit
    (315,642 )     (324,558 )
 
Accumulated other comprehensive loss
    (13,771 )     (37,835 )
 
   
     
 
   
Total stockholders’ equity
    369,085       337,505  
 
   
     
 
 
  $ 814,697     $ 799,997  
 
 
   
     
 

The accompanying notes are an integral part of these consolidated financial statements.

3


Table of Contents

SEMINIS, INC.
Consolidated Statements of Operations

(In thousands, except per share data)

                                     
        For the Three Months Ended   For the Nine Months Ended
       
 
        June 27,   June 28,   June 27,   June 28,
        2003   2002   2003   2002
       
 
 
 
        (Unaudited)   (Unaudited)
Net sales
  $ 113,088     $ 106,564     $ 352,705     $ 338,952  
Cost of goods sold
    42,113       41,581       130,354       128,325  
 
   
     
     
     
 
 
Gross profit
    70,975       64,983       222,351       210,627  
 
   
     
     
     
 
Operating expenses
                               
 
Research and development expenses
    12,564       10,973       34,942       32,483  
 
Selling, general and administrative expenses
    46,685       43,972       138,022       132,500  
 
Amortization of intangible assets
    4,014       4,236       11,907       12,538  
 
   
     
     
     
 
   
Total operating expenses
    63,263       59,181       184,871       177,521  
 
   
     
     
     
 
 
Gain on sale of assets
    366       448       1,457       5,723  
 
   
     
     
     
 
Income from operations
    8,078       6,250       38,937       38,829  
 
   
     
     
     
 
Other income (expense)
                               
 
Interest income
    120       104       626       346  
 
Interest expense
    (8,920 )     (7,186 )     (24,361 )     (21,530 )
 
Foreign currency gain (loss)
    151       2,838       180       (1,504 )
 
Other, net
    (930 )     720       (483 )     410  
 
   
     
     
     
 
 
    (9,579 )     (3,524 )     (24,038 )     (22,278 )
 
   
     
     
     
 
Income (loss) before income taxes
    (1,501 )     2,726       14,899       16,551  
Income tax benefit (expense)
    (1,843 )     1,538       (5,983 )     (5,944 )
 
   
     
     
     
 
Net income (loss)
    (3,344 )     4,264       8,916       10,607  
Preferred stock dividends
    (4,660 )     (3,496 )     (13,844 )     (10,423 )
Additional capital contribution dividends
          (1,164 )           (3,467 )
 
   
     
     
     
 
Net loss available for common stockholders
  $ (8,004 )   $ (396 )   $ (4,928 )   $ (3,283 )
 
   
     
     
     
 
Net loss available for common stockholders per common share:
                               
 
Basic/diluted
  $ (0.12 )   $ (0.01 )   $ (0.08 )   $ (0.05 )
 
   
     
     
     
 

The accompanying notes are an integral part of these consolidated financial statements.

4


Table of Contents

SEMINIS, INC.
Consolidated Statement of Stockholders’ Equity

(In thousands)

                                                     
        Class C   Class A   Class B
        Preferred Stock   Common Stock   Common Stock
       
 
 
        Number   Amount   Number   Amount   Number   Amount
       
 
 
 
 
 
Balance, September 30, 2002
    12     $ 1       18,940     $ 190       45,142     $ 452  
Comprehensive income
                                               
 
Net income (Unaudited)
                                   
 
Translation Adjustment (Unaudited)
                                   
Conversion of additional capital
                                               
 
Contribution to Class C Preferred Stock (Unaudited)
    5                                
Options Exercised (Unaudited)
                73                    
Dividends on Redeemable Preferred Stock (Unaudited)
                                   
 
   
     
     
     
     
     
 
Balance, June 27, 2003
(Unaudited)
    17     $ 1       19,013     $ 190       45,142     $ 452  
 
   
     
     
     
     
     
 

[Additional columns below]

[Continued from above table, first column(s) repeated]
                                     
                        Accumulated        
        Additional           Other   Total
        Paid-In   Accumulated   Comprehensive   Stockholders’
        Capital   Deficit   Loss   Equity
       
 
 
 
Balance, September 30, 2002
  $ 699,255     $ (324,558 )   $ (37,835 )   $ 337,505  
Comprehensive income
                               
 
Net income (Unaudited)
          8,916             8,916  
 
Translation Adjustment (Unaudited)
                24,064       24,064  
 
                           
 
 
                            32,980  
Conversion of additional capital
                               
 
Contribution to Class C Preferred Stock (Unaudited)
                       
Options Exercised (Unaudited)
    100                   100  
Dividends on Redeemable Preferred Stock (Unaudited)
    (1,500 )                 (1,500 )
 
   
     
     
     
 
Balance, June 27, 2003
(Unaudited)
  $ 697,855     $ (315,642 )   $ (13,771 )   $ 369,085  
 
   
     
     
     
 

The accompanying notes are an integral part of these consolidated financial statements.

5


Table of Contents

Consolidated Statements of Cash Flows
(In thousands)

                       
          For the Nine Months Ended
         
          June 27, 2003   June 28, 2002
         
 
          (Unaudited)
Cash flows from operating activities:
               
 
Net income
  $ 8,916     $ 10,607  
 
Adjustments to reconcile net income to net cash used in operating activities:
               
   
Depreciation and amortization
    22,875       23,993  
   
Gain on sale of fixed assets
    (1,457 )     (1,705 )
   
Deferred income taxes
    2,156       3,752  
   
Provision for minority interest subsidiary
    153       616  
   
Inventory write-down
    11,104       12,309  
   
Gain on sale of non-core business
          (4,018 )
   
Compensation expense for restricted stock
          4,359  
   
Other
    915       (4,066 )
   
Changes in assets and liabilities:
               
     
Accounts receivable
    (24,830 )     (14,942 )
     
Inventories
    8,766       5,198  
     
Prepaid expenses and other assets
    (8,591 )     (3,753 )
     
Current income taxes
    (63 )     (3,953 )
     
Accounts payable
    (17,376 )     (25,505 )
     
Other liabilities
    (6,158 )     (448 )
 
   
     
 
   
Net cash provided by (used in) operating activities
    (3,590 )     2,444  
 
   
     
 
Cash flows from investing activities:
               
 
Purchases of fixed and intangible assets
    (9,546 )     (8,767 )
 
Proceeds from disposition of assets
    8,969       25,758  
 
Proceeds from sale of non-core business
          17,551  
 
Other
    (36 )     (569 )
 
   
     
 
   
Net cash provided by (used in) investing activities
    (613 )     33,973  
 
   
     
 
Cash flows from financing activities:
               
 
Proceeds from long-term debt
    686       1,636  
 
Repayment of long-term debt
    (16,754 )     (56,902 )
 
Net short-term borrowings
    8,170       14,981  
 
Other
    100        
 
   
     
 
   
Net cash used in financing activities
    (7,798 )     (40,285 )
 
   
     
 
Effect of exchange rate changes on cash and cash equivalents
    3,326       2,370  
 
   
     
 
Decrease in cash and cash equivalents
    (8,675 )     (1,498 )
Cash and cash equivalents, beginning of period
    36,805       22,323  
 
   
     
 
Cash and cash equivalents, end of period
  $ 28,130     $ 20,825  
 
 
   
     
 

The accompanying notes are an integral part of these consolidated financial statements.

6


Table of Contents

SEMINIS, INC.
Notes to Consolidated Financial Statements

(In Thousands, Except Per Share Data)

Note 1 — Summary of Significant Accounting Policies

Description of Business

Seminis, Inc. (“Seminis,” “we” or the “Company”) is the leading worldwide developer, producer and marketer of vegetable and fruit seeds. The Company is a majority-owned subsidiary of Savia, S.A. de C.V. (“Savia”) and effectively began operations when it purchased Asgrow Seed Company in December 1994.

Basis of Presentation

The consolidated financial statements include the accounts of the Company and its majority controlled and owned subsidiaries. Investments in unconsolidated entities, representing ownership interests between 20% and 50%, are accounted for using the equity method of accounting. All material intercompany transactions and balances have been eliminated in consolidation. Certain reclassifications have been made to prior periods to conform to the current quarter presentation.

Seminis generally operates on a 13 week quarter closing on the Friday closest to the natural calendar quarter, except for the fiscal year end, which closes on September 30.

The unaudited consolidated financial statements included herein reflect all adjustments (consisting only of normal recurring adjustments) that the Company considers necessary for a fair presentation of the results of operations for the interim periods covered and the financial condition of the Company at the date of the interim balance sheet. The Company’s business is subject to seasonal fluctuation and, therefore, the results of operations for periods less than one year are not necessarily indicative of results that may be expected for any other interim period or for the fiscal year as a whole.

Supplementary Cash Flow Information

                   
      Nine Months Ended
     
      June 27,   June 28,
      2003   2002
     
 
      (Unaudited)
Cash paid for interest
  $ 18,288     $ 18,993  
Cash paid for income taxes
    3,890       6,145  
Supplemental non-cash transactions:
               
 
Class C Preferred Stock dividends
          8,923  
 
Class B Redeemable Preferred Stock dividends
    1,500       1,500  
Additional capital contribution dividends
          3,467  

Effective January 2001, shares of Seminis Class C Preferred Stock and additional capital contribution accrue cash dividends at 10% per annum. The Company’s syndicated credit facility, however, precludes the payment of cash dividends. These dividends have not been accrued effective July 1, 2002 in accordance with an amended and restated exchange agreement by and between the Company and Savia, as further described in Note 2. As part of the amended and restated agreement, Savia agreed to forego dividends on its shares of Seminis Class C Preferred Stock and additional capital contributions effective July 1, 2002; however, such dividends would be payable if the transactions described in Note 2 are not completed and the amended and restated agreement is terminated.

Loss per Common Share

Net loss per common share has been computed pursuant to the provisions of Statement of Financial Accounting Standards (“SFAS” ) No. 128, “Earnings per Share.” Basic loss per common share is computed by dividing net loss available to common stockholders by the average number of common shares outstanding during each period. Net loss available to common stockholders represents reported net income (loss) less preferred and additional capital contribution dividends. Diluted net loss per common share reflects the potential

7


Table of Contents

dilution that could occur if dilutive securities and other contracts were exercised or converted into common stock or resulted in the issuance of common stock. The following table provides a reconciliation of net income (loss) and sets forth the computation for basic and diluted net loss per share available for common stockholders.

                                   
      Three Months Ended   Nine Months Ended
      June 27,   June 28,   June 27,   June 28,
      2003   2002   2003   2002
     
 
 
 
      (Unaudited)   (Unaudited)
Numerator for basic and diluted:
                               
Net income (loss)
  $ (3,344 )   $ 4,264     $ 8,916     $ 10,607  
Preferred stock dividends
    (500 )     (3,496 )     (1,500 )     (10,423 )
Additional capital contribution dividends
          (1,164 )           (3,467 )
Contingent dividends payable
    (4,160 )           (12,344 )      
 
   
     
     
     
 
 
Net loss available for common stockholders
  $ (8,004 )   $ (396 )   $ (4,928 )   $ (3,283 )
 
   
     
     
     
 
Denominator — shares:
                               
 
Weighted average common shares outstanding (basic)
    64,155       62,746       64,111       61,619  
 
Add: potential common shares:
                       
 
   
     
     
     
 
 
Weighted average common shares outstanding (diluted)
    64,155       62,746       64,111       61,619  
 
   
     
     
     
 
Net loss available for common Stockholders per common share:
                               
 
Basic/ diluted
  $ (0.12)/(0.12 )   $ (0.01)/(0.01 )   $ (0.08)/(0.08 )   $ (0.05)/(0.05 )
 
   
     
     
     
 

A total of 4.1 million potential shares from options were excluded from the computation of diluted earnings per share for the three and nine months ended June 27, 2003, due to their antidilutive effect. A total of 4.4 million potential shares from options were excluded from the computation of diluted earnings per share for the three and nine months ended June 28, 2002, due to their antidilutive effect.

Contingently payable dividends represent dividends that may be payable to Savia if the exchange contemplated by the amended and restated exchange agreement described in Note 2 is not consummated. As part of the amended and restated exchange agreement, Savia agreed to forego dividends on its shares of Seminis Class C Preferred Stock and additional capital contributions effective July 1, 2002; however, such dividends would be payable if the transactions contemplated by the amended and restated exchange agreement are not completed and the amended and restated exchange agreement is terminated. These dividends have not been accrued but are included in the calculation of earnings per share.

Recent Accounting Pronouncements

In August 2001, the Financial Accounting Standards Board (“FASB”) issued SFAS No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets.” SFAS No. 144 supersedes SFAS No. 121 but retains many of its fundamental provisions. In addition, SFAS No. 144 expands the scope of discontinued operations to include more disposal transactions. We have adopted SFAS No. 144 as of October 1, 2002. The adoption of SFAS No. 144 did not have a material effect on our consolidated financial position, results of operations or cash flows.

In May 2002, the FASB issued SFAS No. 145, “Rescission of SFAS Nos. 4, 44 and 64, Amendment of SFAS No. 13 and Technical Corrections.” Among other things, SFAS No. 145 rescinds various pronouncements regarding extinguishment of debt and allows extraordinary accounting treatment for early extinguishment only when the provisions of Accounting Principles Board Opinion No. 30, “Reporting the Results of Operations-Reporting the Effects of Disposal of a Segment of a Business and Extraordinary, Unusual and Infrequent Occurring Events and Transactions” are met. SFAS No. 145 provisions regarding early extinguishment of debt are generally effective for fiscal years beginning after May 15, 2002. Accordingly, SFAS No. 145 was adopted by the Company on October 1, 2002. Such adoption did not have an impact on our business, consolidated financial position, results of operations or cash flow.

In June 2002, the FASB issued SFAS No. 146, “Accounting for Costs Associated with Exit or Disposal Activities.” SFAS No. 146 supersedes previous accounting guidance, principally Emerging Issues Task Force Issue No. 94-3, “Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (Including Certain Costs Incurred in a Restructuring).”

8


Table of Contents

SFAS No. 146 requires that the liability for costs associated with an exit or disposal activity be initially measured at fair market value and recognized when the liability is incurred. In periods subsequent to initial measurement, changes to the liability are measured using the credit-adjusted risk-free rate that was used in the initial measurement of the liability recorded. The cumulative effect of a change resulting from revisions either to the timing or the amount of estimated cash flow is recognized as an adjustment to the liability in the period of the change and charged to the same line items in the statement of operations used when the related costs were initially recognized. Under EITF No. 94-3, a liability for an exit cost was recognized at the date of the Company’s commitment to an exit plan.

The provisions of SFAS No. 146 are required to be applied prospectively to exit or disposal activities initiated after December 31, 2002. The Company believes SFAS No. 146 may affect the timing of recognizing future restructuring costs, as well as the amounts recognized, depending on the nature of the exit or disposal activity and the timing of the related estimated cash flows.

On November 25, 2002, the Financial Accounting Standards Board issued FASB Interpretation No. (“FIN” 45, “Guarantor’s Accounting and Disclosure Requirements for Guarantees of Indebtedness of Others, Including Indirect Guarantees of Indebtedness of Others, an interpretation of FASB Statements No. 5, 57 and 107 and Rescission of FASB interpretation No. 34.” FIN 45 clarifies the requirements of FASB Statement No. 5, Accounting for Contingencies, relating to the guarantor’s accounting for and disclosure of, the issuance of certain types of guarantees. The disclosure provisions of the interpretation are effective for financial statements of interim or annual periods that end after December 15, 2002. Accordingly, the Company adopted FIN 45 during the quarter ended December 27, 2002. The Company has no guarantees that would require disclosure under FIN 45.

In January 2003, the FASB issued SFAS No. 148, “Accounting for Stock-Based Compensation-Transition and Disclosure, an amendment of FASB Statement No. 123.” SFAS No. 148 provides alternative methods of transition for a voluntary change to the fair value based method of accounting for stock-based employee compensation. It also requires disclosures in both annual and interim financial statements about the method of accounting for stock-based employee compensation and the effect of the method used on reported results. SFAS No. 148 is effective for annual and interim periods beginning after December 15, 2002. As we have elected not to change to the fair value based method of accounting for stock-based employee compensation, the adoption of SFAS No. 148 will not have an impact upon our financial condition or results of operations.

In January 2003, the FASB issued Interpretation No. 46, “Consolidation of Variable Interest Entities – an Interpretation of Accounting Research Bulletin (“ARB”) No. 51.” This interpretation clarifies the application of ARB No. 51, “Consolidated Financial Statements,” to certain entities in which equity investors do not have the characteristics of a controlling financial interest or do not have sufficient equity at risk for the entity to finance its activities without additional subordinated financial support from other parties. The provisions of this Interpretation are effective for all enterprises with variable interests in variable interest entities created after January 31, 2003. The adoption of this Interpretation did not have a significant impact on the Company’s financial condition or results of operations.

In April 2003, the FASB issued SFAS No. 149, “Amendment of Statement 133 on Derivative Instruments and Hedging Activities.” This Statement amends and clarifies financial accounting and reporting for derivative instruments, including certain derivative instruments embedded in other contracts (collectively referred to as derivatives) used for hedging activities under SFAS No. 133, “Accounting for Derivative Instruments and Hedging Activities.” The provisions of this Statement are effective for contracts entered into or modified after June 30, 2003 and for hedging relationships designated after June 30, 2003. The adoption of this Statement is not expected to have significant impact on the Company’s financial condition or results of operations.

In May 2003, the FASB issued SFAS No. 150, “Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity.” This Statement establishes standards for how an issuer classifies and measures certain financial instruments with characteristics of both liabilities and equity. This Statement requires that an issuer classify a financial instrument that is within its scope as a liability (or an asset in some circumstances). The provisions of this Statement are effective for financial instruments entered into or modified after May 31, 2003, and otherwise are effective at the beginning of the first interim period beginning after June 15, 2003. Upon adoption of this Statement, the Company will have to restate the carrying value of its mandatorily redeemable preferred stock to the present value of this obligation and reclassify this amount into liabilities on the balance sheet. Additionally, amounts previously accrued as dividends on the mandatorily redeemable preferred stock will be expensed in the statement of operation as interest expense.

Note 2 — Liquidity

As of September 30, 2000, we were not in compliance with certain covenants of our existing syndicated credit facility, which gave the lenders the right to accelerate payment of all amounts outstanding under the facility. In December 2000, the lenders granted a waiver with respect to these covenants that extended through April 30, 2001, at which time any defaults would once again arise. As we did

9


Table of Contents

not expect to be in compliance with our covenants once the waiver expired, all outstanding borrowings under the syndicated credit facility were classified as a current liability as of September 30, 2000. In connection with granting the waivers, the lenders agreed to reschedule principal payments within fiscal year 2001. The lenders also accelerated the final maturity of the term loan and the termination date for the revolving credit commitments to June 30, 2002 from June 30, 2004. We were obligated to deliver a financial plan through September 30, 2002, which detailed cash flow projections on a monthly basis as well as proposed alternatives for the refinancing of the syndicated credit facility or recapitalization of the Company.

On May 31, 2001, our lenders agreed with the financial plan that we submitted and agreed to restructure our existing syndicated credit facility. Upon receipt of the amended syndicated credit facility, long-term portions of borrowings were reclassified from current liabilities to long-term debt. Among other things, the amendment extended the final maturity of the syndicated credit facility from the previously agreed on date of June 30, 2002 to December 31, 2002, revised principal payment dates under the term loan, instituted a new grid pricing formula to determine interest on borrowings and revised covenant obligations. Interim principal obligations under the amendment included $16.0 million due in the fourth quarter of fiscal year 2001 and $19.0 million, $4.0 million, $31.0 million and $9.0 million due in the first, second, third and fourth quarters of fiscal year 2002, respectively. All remaining amounts were due in the first quarter of fiscal year 2003.

In October 2001, we completed the sale of an office building in Seoul, South Korea, which generated net proceeds of approximately $20.0 million. We used $19.5 million of the proceeds to make the scheduled $19.0 million payment on the syndicated credit facility in October 2001. We also sold one of our non-core businesses in January 2002, which generated additional proceeds of approximately $17.6 million. We used $13.0 million of the proceeds to prepay our existing syndicated credit facility in January 2002 and utilized our operating cash flow to pay the remaining $18.0 million in June 2002.

We met all required principal and interest payments during fiscal years 2002 and 2001 and were in compliance with all of our financial covenants under the amended syndicated credit facility at September 30, 2002. In October 2002, we paid an additional $5.0 million of principal as required by the amended syndicated credit facility; however, as of December 31, 2002, we had not completed a refinancing transaction in order to pay the remaining balance of $224.7 million. The lenders agreed to temporarily extend the term of the syndicated credit facility and in January 2003, a formal amendment was executed. Among other things, the amendment extended the final maturity of the syndicated credit facility from the previously agreed on date of December 31, 2002 to December 31, 2003, revised principal payment dates under the term loan, instituted a new grid pricing formula to determine interest on borrowings and revised covenant obligations. Outstanding interim principal obligations under the amendment included $6.0 million due in the fourth quarter of fiscal year 2003. The remaining outstanding amount totaling $210.6 million will be due in the first quarter of fiscal year 2004. We met all required principal and interest payments and were in compliance with all of our financial covenants at June 27, 2003 under the newly extended amendment. As all remaining amounts under the amended syndicated credit facility are due within one year, the $216.6 million of outstanding borrowings under the syndicated credit facility has been classified as a current liability as of June 27, 2003.

On May 30, 2003, we and/or certain other parties entered into an amended and restated exchange agreement, a contribution agreement, an agreement and plan of merger, a stock purchase agreement and certain other related agreements pursuant to which an acquisition company was formed at the direction of Fox Paine & Company, LLC, a San Francisco based private equity firm, to acquire all of the outstanding shares of the Company’s common stock. Public holders of approximately 15.8 million shares of Seminis common stock will receive cash consideration of $3.78 per share in the merger. Immediately following the merger and related transactions, Fox Paine, its affiliates and co-investors will own approximately 75% of the shares of Seminis common stock outstanding following the completion of the transactions, and the remaining shares will be owned by certain affiliates of Alfonso Romo Garza, Seminis’ and Savia’s current Chairman and Chief Executive Officer, certain creditors of a Savia affiliate and nine members of Seminis and Savia management. Additionally, certain entities affiliated with Mr. Romo will receive co-investment rights to purchase, subject to certain conditions, up to 34% of the outstanding shares of Seminis common stock following the transactions. Following the merger and related transactions, the Company will be privately held and Seminis common stock will no longer be listed on The Nasdaq National Market. Seminis stockholders representing approximately 85% of the voting power represented by the outstanding shares of Seminis common stock currently entitled to vote have entered into a voting agreement to vote in favor of the merger.

Prior to the consummation of the merger and pursuant to the terms of the amended and restated exchange agreement, Savia will exchange all of its outstanding shares of Seminis Class C preferred stock (including accrued Paid In Kind (“PIK”) dividends) having a principal value of $120.2 million, additional paid-in capital (including accrued PIK dividends) of $46.7 million and accrued and unpaid dividends for 37.7 million shares of Seminis Class A Common Stock and cash equal to $15.0 million plus interest at a rate of 10.0% per annum from July 1, 2002, less $3.0 million.

10


Table of Contents

Although we have met our obligations and covenant requirements under the amended syndicated credit facility through June 27, 2003, we must successfully execute a refinancing plan prior to December 31, 2003 in order to meet the final maturity of the facility. The consummation of the proposed transactions require the Company’s amended syndicated credit facility to be refinanced. It is anticipated that the proposed transactions would be funded, in part, by financing arranged by the newly-formed acquisition company. There can be no assurances that the merger and related transactions will be consummated. Failure to comply with existing covenants in the amended syndicated credit facility, which would make the facility callable, or our inability to refinance the facility prior to December 31, 2003, could have a material adverse impact on our business, results of operations or financial condition.

Note 3 — Inventories

Inventories consist of the following:

                 
    June 27, 2003   September 30, 2002
   
 
    (Unaudited)        
Seed
  $ 236,622     $ 238,448  
Unharvested crop growing costs
    21,880       27,199  
Supplies
    7,648       6,880  
 
   
     
 
 
  $ 266,150     $ 272,527  
 
   
     
 

Note 4 — Goodwill

Changes in the net carrying amount of goodwill for the period ended June 27, 2003, are as follows:

           
      Amount
     
Balance as of September 30, 2002
  $ 98,931  
 
Goodwill acquired during the period (unaudited)
    304  
 
Impairment losses (unaudited)
     
Translation adjustments and other (unaudited)
    3,471  
 
   
 
Balance as of June 27, 2003 (unaudited)
  $ 102,706  
 
   
 

Goodwill acquired during the period resulted from the purchases of minority holdings of Selekta, a South African subsidiary and Nath Sluis, an Indian subsidiary.

Note 5 — Intangibles

The following table sets forth the Company’s intangible assets, at June 27, 2003 and September 30, 2002, which continue to be amortized:

                                                 
    June 27, 2003   September 30, 2002
   
 
    Gross   Accumulated   Net   Gross   Accumulated   Net
    Carrying Amount   Amortization   Carrying Amount   Carrying Amount   Amortization   Carrying Amount
   
 
 
 
 
 
    (Unaudited)   (Unaudited)   (Unaudited)                        
Amortizable intangible assets:
                                               
Germplasm
  $ 101,948     $ 76,614     $ 25,334     $ 99,844     $ 71,431     $ 28,413  
Software costs
    35,984       25,585       10,399       33,922       20,697       13,225  
Trademarks
    14,900       8,306       6,594       14,900       7,772       7,128  
Other intangibles
    27,653       15,466       12,187       25,953       12,847       13,106  
 
   
     
     
     
     
     
 
Total
  $ 180,485     $ 125,971     $ 54,514     $ 174,619     $ 112,747     $ 61,872  
 
   
     
     
     
     
     
 

Amortization expense on intangible assets was $4.0 and $4.2 million for the three months ended June 27, 2003 and June 28, 2002, respectively; and $11.9 and $12.5 million for the nine months ended June 27, 2003 and June 28, 2002, respectively. Based on current information, estimated amortization expense for acquired intangible assets for this fiscal year, and for each of the next four succeeding fiscal years, is expected to be approximately $15.8, $14.5, $13.5, $12.6 and $12.0 million, respectively.

11


Table of Contents

Note 6 — Accrued Liabilities

Accrued liabilities consist of the following at June 27, 2003 and September 30, 2002:

                 
    June 27, 2003   September 30, 2002
   
 
    (Unaudited)        
Employee salaries and related benefits
  $ 44,833     $ 44,754  
Severance
    555       3,269  
Seedmen’s errors and omissions
    5,291       4,072  
Interest
    387       412  
Savia dividends and interest payable
    26,548       25,383  
Income taxes payable
    3,075       3,236  
Other
    16,529       17,498  
 
   
     
 
 
  $ 97,218     $ 98,624  
 
   
     
 

Note 7 — Stock-Based Compensation

The Company has a policy whereby all stock option grants are priced at fair market value on the date of grant. Under the provisions of SFAS No. 123, “Accounting for Stock-Based Compensation,” the Company uses the intrinsic value method of accounting for stock-based compensation in accordance with Accounting Principles Board (APB) Opinion No. 25, “Accounting for Stock Issued to Employees.” Under the intrinsic value method, compensation cost is the excess, if any, of the quoted market price of the stock at the grant date or other measurement date over the amount an employee must pay to acquire the stock.

In accordance with the disclosure provisions of SFAS No. 148, “Accounting for Stock-Based Compensation-Transition and Disclosures,” the following table reflects pro forma net income and earnings per share had the Company elected to adopt the fair value approach of SFAS No. 123:

                                 
    For The Three Months Ended   For The Nine Months Ended
   
 
    June 27, 2003   June 28, 2002   June 27, 2003   June 28, 2002
   
 
 
 
    (Unaudited)   (Unaudited)
Net loss available for common stockholders, as reported
  $ (8,004 )   $ (396 )   $ (4,928 )   $ (3,283 )
Compensation expense, net of tax
    (182 )     (258 )     (547 )     (578 )
 
   
     
     
     
 
Pro forma net loss available for common stockholders
  $ (8,186 )   $ (654 )   $ (5,475 )   $ (3,861 )
 
   
     
     
     
 
Net loss available for common stockholders per common share as reported:
                               
Basic/ diluted
  $ (0.12 )   $ (0.01 )   $ (0.08 )   $ (0.05 )
Pro forma net loss available for common stockholders per common share:
                               
Basic/diluted
  $ (0.13 )   $ (0.01 )   $ (0.09 )   $ (0.06 )

12


Table of Contents

Note 8 — Contingencies

In January 2002, melon growers in Costa Rica notified us that our Dorado melon seeds were infected with watermelon fruit blotch. Growers who purchased the infected Seminis seeds and growers whose crops were infected by the bacteria that spread from crops grown with the infected seeds have claimed damages against us. The claims by those growers who purchased Seminis seeds have been settled for approximately $5.8 million, of which, approximately $2.6 million was recovered under our errors and omissions insurance policy and the remainder of the settlement was paid by the Company by July 2002. The claims by the growers with infected crops total approximately $4.7 million and we believe these claims are covered under our general liability insurance policy. We have finalized a settlement of nearly all of these claims. Our general liability insurance carrier continues to deny coverage, and we are continuing to negotiate with them on this matter. In the event we cannot finalize the settlement with our general liability insurance carrier, we plan to seek all legal remedies and redress available to us against the carrier.

In early 2000, we filed a suit against Dietrich Schmidt, the former president of Seminis and the current president of United Genetics, a competitor of ours, United Genetics and two former Seminis breeders, Ken Owen and Wei Ouyang, for trade secret misappropriation and breach of contract. Schmidt filed a counterclaim for defamation against us. We were unsuccessful on our claims for trade secret misappropriation and breach of contract and Schmidt was successful on his counterclaim, with the court awarding him $1 in nominal damages. The court subsequently awarded Schmidt, Owen and Ouyang their attorneys’ fees. We have appealed certain aspects of the judgment, including the fee award. The appeal is still pending and is not expected to be decided until late 2003.

Between December 17, 2002 and January 31, 2003, five purported class action lawsuits were filed relating to the proposed transaction under which Fox Paine and several Savia-related parties would acquire all of the outstanding shares of Seminis. Four of these actions — Garry Firth v. Alfonso Romo Garza, et al., Civil Action No. 20085, Boris Pozniak v. Alfonso Romo Garza, et al., Civil Action No. 20097, Pablo Herranz v. Seminis, Inc., et al., Civil Action No. 20105 and Haven Capital Management v. Seminis, Inc., et al., Civil Action No. 20140-NC were filed in the Delaware Court of Chancery (New Castle, County), while the fifth, Mark Rosales v. Seminis, Inc., Case No. CIV216255, was filed in California Superior Court (Ventura County). In February 2003, the Firth, Pozniak, Herranz and Haven Capital cases were consolidated into one proceeding entitled In re Seminis, Inc. Shareholders’ Litigation, Consolidated C.A. No. 20140-NC and the Haven Capital complaint was designated as the operative complaint in the consolidated lawsuit. That complaint names as defendant’s Savia, Seminis and Seminis’ directors. The Rosales (California) complaint names as defendants Seminis and its directors. Both the Delaware consolidated action and the Rosales action purport to be brought on behalf of Seminis common stockholders or their successors. Both of these actions-which were brought prior to the public announcement of Seminis entering into the merger agreement-allege that the merger, if consummated, would provide insufficient consideration to Seminis common stockholders and allege that the defendants breached their fiduciary duties in connection with the transaction. The complaints seek a preliminary and permanent injunction to enjoin the transaction and, in the event the transaction is consummated, rescission and damages. No provision for loss has been made in the accompanying consolidated financial statements, as the probability of an unfavorable outcome and the amount of loss, if any, are not determinable at this time.

During the last months of fiscal year 2002, Seminis’ subsidiary in Spain sold Boludo tomato seed to growers in the Canary Islands of Spain. Subsequently, some fields planted with this seed showed symptoms of the bacteria, Clavibacter michiganses, which can be seed borne, among other possible sources. Seminis has been conducting an investigation of the seeds and until July 31, 2003, all Seminis seed used in these fields that had been tested, tested negative for the presence of the bacteria. Spanish authorities requested an analysis of all seed lots sold in the Canary Islands. On July 31, 2003, Seminis was notified that after analyzing 89 lots of Boludo seed, a single seed lot tested positive for the presence of the bacteria. Seminis believes that other factors that may cause the disease were present at the time of the infection, and could be responsible for, or contributing factors to, the presence of the bacteria and damage to the crops. These factors include, but are not limited to: poor sanitary practices in the growers’ fields (failure to remove debris from prior harvests); bacteria from sources other than Seminis that remained in the fields from prior seasons; the practice of grafting, which can magnify the effects of small outbreaks and weaken the crops; failure to properly rotate crops from season to season; and third-party isolates (different strains) of the disease that may have been present. Seminis continues to investigate this matter vigorously, in particular investigating the single positive test result, which is inconsistent with the findings of all of the other independent laboratories’ test results for Seminis seed lots. Seminis does not believe that its Boludo tomato seeds sold in the Canary Islands caused any bacterial damage. Notwithstanding the foregoing, tomato growers may initiate legal claims against the Company alleging that Seminis seeds were the source of the bacteria and claiming significant damages and Seminis cannot predict the outcome of any such claims, if initiated.

We are involved from time to time as a defendant in various other lawsuits arising in the normal course of business. We believe that no current claims, individually or in the aggregate, will have a material adverse effect on our business, results of operations or financial condition.

13


Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis should be read in conjunction with the consolidated financial statements, including the notes thereto, appearing elsewhere herein. The following discussion and analysis contains certain “forward-looking statements”, which are subject to certain risks, uncertainties and contingencies, including, without limitation, those set forth below, which could cause Seminis’ actual business, results of operations or financial condition to differ materially from those expressed in or implied by such statements.

RISK FACTORS

Readers should be aware that there are various risk factors including, but not limited to, those set forth below:

  We have experienced losses in the past and we may experience losses in the future.
 
  As of December 31, 2002, we had not completed a refinancing transaction in order to pay the remaining balance of our syndicated credit facility totaling $224.7 million. The lenders agreed to temporarily extend the term of the syndicated credit facility and in January 2003, a formal amendment was executed. Among other things, the amendment extended the final maturity of the syndicated credit facility from the previously agreed upon date of December 31, 2002 to December 31, 2003, revised principal payment dates under the term loan, instituted a new grid pricing formula to determine interest on borrowings and revised covenant obligations. Outstanding interim principal obligations under the amendment included $6.0 million due in the fourth quarter of fiscal year 2003. The remaining outstanding amount totaling $210.6 million will be due in the first quarter of fiscal year 2004. Whereas we have met our obligations as well as covenant requirements under the amended syndicated credit facility through June 27, 2003, we must successfully execute a refinancing plan prior to December 31, 2003 in order to meet the final maturity of the facility. We will continue to pursue a refinancing plan, which may include negotiation of a new syndicated credit facility and/or placement of new debt securities; however, there can be no assurances that we will be able to successfully complete the refinancing. Additionally, there can be no assurances that the proposed transaction as further described below under the caption “Overview—Liquidity and Capital Resources” with the Company, Savia and Fox Paine will be consummated. Failure to comply with existing covenants, which would make the amended syndicated debt callable or our inability to obtain adequate financing with reasonable terms prior to December 31, 2003 could have a material adverse impact on our business, results of operations or financial condition.
 
  The Company is currently restricted from any additional borrowings under the syndicated credit facility. As of November 2000, Savia suspended advancing funds to the Company.
 
  Savia owns approximately 63.4% of the Company’s outstanding common stock and controls approximately 78.9% of the vote of its common stock. Accordingly, Savia controls the Company and has the power to approve all actions requiring the approval of our stockholders, including the power to elect all of its directors. Therefore, Savia effectively controls our management.
 
  The Company continues to invest in research and development in order to enable us to identify and develop new products to meet consumer demands. In fiscal year 2002, our investment in research and development represented 9.8% of net sales. Despite investments in this area, our research and development may not result in the discovery or successful development of new products, which will be accepted by our customers.
 
  The Company may not have the ability to protect its intellectual property due to the uncertainty of litigation and the ineffectiveness of the laws in some of the countries that the Company currently has operations, which could have a material adverse effect on our business, results of operations or financial condition.
 
  A change in U.S. law protecting plant patents could limit or take away patent protection for the Company’s patented seeds, which could have a material adverse effect on our business, results of operations or financial condition.
 
  The Company faces substantial competition due to technological advances by competitors such as other seed companies, pharmaceutical and chemical companies and biotechnology companies. Many of these companies have substantially greater resources than the Company. If a competitor introduces a competitively successful product, it could take years to develop a competitive seed variety, which could have a material adverse effect on our business, results of operations or financial condition.

14


Table of Contents

  The Company’s failure to accurately forecast and manage inventory could result in an unexpected shortfall or surplus of seeds, which could have a material adverse effect on our business, results of operations or financial condition.
 
  Extreme weather conditions, disease and pests can materially and adversely affect the quality and quantity of seeds produced. There can be no assurance that these factors will not affect a substantial portion of the Company’s production in any year and have a material adverse effect on our business, results of operations or financial condition.
 
  Defective seeds could result in claims and negative publicity, and the insurance covering claims may become unavailable or be inadequate, which could have a material adverse effect on our business, results of operations or financial condition.
 
  The Company owns production and processing facilities in numerous countries throughout the world and markets its products worldwide. Accordingly, fluctuations in currency rates may affect the Company’s operating results and net income.
 
  The Company’s business is seasonal.
 
  The Company’s worldwide operation and products are highly regulated in the areas of safety and protection of human health and the environment. Compliance with these health and safety regulations can be costly.

OVERVIEW

Seminis is the leading worldwide developer, producer and marketer of vegetable and fruit seeds. We produce more than 60 species and 4,000 vegetable and fruit seed products (which do not include tree and citrus fruits). We market our seeds through four full-line brands — Seminis, Asgrow, Petoseed and Royal Sluis — and five specialty and regional brands. We have established a worldwide presence and global distribution system. We market seeds in over 150 countries, have 48 research and development facilities in 17 countries and territories and production sites in over 25 countries, which allows us to remain close to local markets around the world, adapt our products to any microclimate and meet the preferences of local consumers.

Seminis was formed in 1994 to consolidate various industry-leading vegetable and fruit seed brands into one consumer-oriented producer and marketer of vegetable and fruit seeds. Our core business was created through the acquisition of the Asgrow seed business in December 1994 and the subsequent combination of the Asgrow business with the Petoseed and Royal Sluis seed businesses in October 1995. Since our formation, we have been at the forefront of the consolidation of the vegetable and fruit seed industry and have completed ten acquisitions.

Our rapid growth through acquisitions created a highly complex operation that impacted our results. An increasing level of inventory as well as production and quality assurance difficulties were the primary operating problems that resulted in us experiencing severe financial difficulties over the past several years.

Global Restructuring and Optimization Plan

     In February 2000, we announced a cost-saving initiative designed to streamline operations, increase utilization of facilities and improve efficiencies. The first phase of the initiative, which commenced in fiscal year 2000 and focused on North American operations, was completed by the end of fiscal year 2001. In June 2001, we commenced the second phase, which was targeted at our global operations and expanded the phase to cover additional headcount reductions and to consolidate our facilities in Holland. The key elements to the Global Restructuring and Optimization Plan involve:

  reorganizing our 10 legacy seed companies into four geographical regions;
 
  selling or consolidating certain operation and production facilities;
 
  reducing headcount in connection with the reorganization and facility consolidation;
 
  rationalizing our product portfolio;
 
  implementing an advanced logistics management information system; and

15


Table of Contents

  divesting non-strategic assets.

In connection with phase one of the Global Restructuring and Optimization Plan, we recorded pre-tax charges to operations of approximately $34.4 million for restructuring costs during fiscal year 2000 that included severance and other exit costs, inventory write-downs and costs associated with streamlining our products portfolio. Of this amount, $18.4 million was included in cost of goods sold for inventory write-downs. The remaining $16.0 million was included in selling, general and administrative expenses and consisted primarily of severance costs. The total phase one and initial phase two severance charges related to a planned 600-employee reduction worldwide in both operational and administrative groups.

As part of the implementation of the expanded second phase of our Global Restructuring and Optimization Plan, we recorded a pre-tax charge of $12.0 million in selling, general and administrative expenses in the third quarter of fiscal year 2001. This charge was primarily related to severance and related costs resulting from an additional planned 250-employee reduction worldwide in both operational and administrative groups. In fiscal year 2001, we also recorded non-cash inventory write-downs of $58.2 million in cost of goods sold in order to comply with more stringent seed quality standards and to further rationalize our product portfolio from 6,000 to 4,000 varieties. We believe we have established adequate reserves for all of the remaining costs and expenses related to our Global Restructuring and Optimization Plan.

     The remaining components of the restructuring accruals are as follows:

(In Millions)

                                                                                         
            Amounts   Balance at   Additional   Amounts   Balance at   Additional   Amounts   Balance at   Amounts   Balance at
    Charges   Incurred   Sept. 30,   Charges   Incurred   Sept. 30,   Charges   Incurred   Sept. 30,   Incurred   June 27,
    2000   2000   2000   2001   2001   2001   2002   2002   2002   2003   2003
   
 
 
 
 
 
 
 
 
 
 
                                                                            (Unaudited)   (Unaudited)
Severance and related expenses
  $ 14.0     $ (1.8 )   $ 12.2     $ 12.0     $ (12.3 )   $ 11.9     $     $ (8.6 )   $ 3.3     $ (2.7 )   $ 0.6  
Inventory write-downs
    18.4       (18.4 )           58.2       (58.2 )                                    
Other
    2.0       (2.0 )                                                      
 
   
     
     
     
     
     
     
     
     
     
     
 
Total
  $ 34.4     $ (22.2 )   $ 12.2     $ 70.2     $ (70.5 )   $ 11.9     $     $ (8.6 )   $ 3.3     $ (2.7 )   $ 0.6  
 
   
     
     
     
     
     
     
     
     
     
     
 

As of June 27,2003, there have been no material adjustments to amounts accrued under our Global Restructuring and Optimization Plan. The remaining $0.6 million reserve balance is expected to be utilized in fiscal year 2003.

Results of Operations

The table below sets forth Seminis’ results of operations data expressed as a percentage of net sales.

                                 
    Three Months Ended   Nine Months Ended
   
 
    June 27,   June 28,   June 27,   June 28,
    2003   2002   2003   2002
   
 
 
 
    (Unaudited)   (Unaudited)
Net sales
    100.0 %     100.0 %     100.0 %     100.0 %
 
   
     
     
     
 
Gross profit
    62.8       61.0       63.0       62.1  
Research and development expenses
    11.1       10.3       9.9       9.6  
Selling, general and administrative expenses
    41.3       41.3       39.1       39.1  
Amortization of intangible assets
    3.6       4.0       3.4       3.7  
 
   
     
     
     
 
Total operating expenses
    56.0       55.6       52.4       52.4  
Gain on sale of assets
    0.3       0.4       0.4       1.7  
 
   
     
     
     
 
Income from operations
    7.1       5.8       11.0       11.4  
Interest expense, net
    (7.8 )     (6.6 )     (6.7 )     (6.2 )
Other non-operating income (expense), net
    (0.7 )     3.4       (0.1 )     (0.3 )
 
   
     
     
     
 
Income (loss) before income taxes
    (1.4 )     2.6       4.2       4.9  
Income tax benefit (expense)
    (1.6 )     1.4       (1.7 )     (1.8 )
 
   
     
     
     
 
Net income (loss)
    (3.0 )%     4.0 %     2.5 %     3.1 %
 
   
     
     
     
 

16


Table of Contents

Nine months ended June 27, 2003 compared with nine months ended June 28, 2002

Net sales

Net sales increased 4.1% to $352.7 million for the nine months ended June 27, 2003 from $339.0 million for the same period ended June 28, 2002. The increase was primarily due to $21.0 million of favorable currency fluctuations relating to the strengthening of the Euro and South Korean Won versus the U.S. Dollar during the nine months ended June 27, 2003, compared to the same period in the prior fiscal year, partially offset by $2.0 million decrease reflecting the divestiture of a non-core business in January 2002. In constant dollars, stated at monthly average exchange rates of fiscal year 2002, and excluding the sales of the divested and phased out non-core businesses, sales would have decreased 1.5%. Despite a general seed price increase in all the regions, sales were affected by volume decrease and product mix. This decrease was primarily due to weaker sales in the Far East that were attributable to a reduction of acreage for hot pepper varieties and demand for watermelon varieties and the decrease of certain carrot and hot pepper sales in the NAFTA region. Our business is subject to seasonal fluctuations and, therefore, the sales for the nine months of a fiscal year are not necessarily indicative of those to be expected in any other interim period or for an entire fiscal year.

Gross Profit

Gross profit increased 5.6% to $222.4 million for the nine months ended June 27, 2003 from $210.6 million for the nine months ended June 28, 2002. Gross margin increased to 63.0% for the nine months ended June 27, 2003 from 62.1% for the nine months ended June 28, 2002. The increase was primarily due to general seed price increases in all regions as well as an improved product mix.

Research and Development Expenses

Research and development expenses increased 7.6% to $34.9 million for the nine months ended June 27, 2003 from $32.5 million for the nine months ended June 28, 2002. The increase was primarily due to the currency fluctuation impact on research and development expenses denominated in the Euro and South Korean Won, and general increases from year to year.

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased 4.2% to $138.0 million for the nine months ended June 27, 2003 from $132.5 million for the nine months ended June 28, 2002. The increase was primarily attributable to an expense of $4.4 million related to an executive severance package, the impact of an additional $3.3 million in severance expenses, the incurrence of $2.4 million of legal and financial advisory expenses related to the proposed merger and related transaction and currency fluctuation impact during this fiscal year. The increases were partially offset by decreases of $2.9 million of expenses related to a divested non-core business, $5.5 million of restricted stock award expenses and $0.8 million of consulting fees related to restructuring during the same period last fiscal year.

Amortization of Intangible Assets

Amortization of intangible assets decreased 5.0% to $11.9 million for the nine months ended June 27, 2003 from $12.5 million for the nine months ended June 28, 2002. The decrease was primarily due to the effect of latter stages of accelerated amortization of intangible assets related to purchase accounting. The decrease was partially offset by the currency impact from the fluctuation of the South Korean Won on South Korea-based intangible assets.

Gain on Sale of Assets

The gain on sale of assets of $1.5 million for the nine months ended June 27, 2003 was primarily due to the sale of certain South Korean assets, a Salinas, California property and a company-owned house. The gain on sale of assets of $5.7 million for the nine months ended June 28, 2002 was primarily due to the sale of a non-core business and asset sales of our South Korean subsidiary.

Interest Expense, Net

Interest expense, net, increased 12.0% to $23.7 million for the nine months ended June 27, 2003 from $21.2 million for the nine months ended June 28, 2002. The increase was primarily due to amortization of increased deferred financing fees and higher interest rates resulting from the amendment of the Company’s syndicated credit facility in January 2003, offset by the effect of lower average debt balances.

17


Table of Contents

Other Non-Operating Income (expense), Net

We had other non-operating expense, net, including foreign currency gain (loss), net, of $0.3 million for the nine months ended June 27, 2003, as compared to other non-operating expense, net, of $1.1 million for the nine months ended June 28, 2002. Other non-operating expense, net, for the nine months ended June 27, 2003 primarily consisted of non-operating losses from subsidiaries in the United States, Guatemala, Chile, Brazil and Italy. Other non-operating expense, net, for the nine months ended June 28, 2002 primarily consisted of foreign currency losses of $1.5 million resulting from currency fluctuations in South America and a U.S. Dollar denominated loan in the Netherlands.

Income Tax Expense

Income tax expense was $6.0 million for the nine months ended June 27, 2003 compared to income tax expense of $5.9 million for the nine months ended June 28, 2002. The year-to date effective tax rate increased to 40.2% for 2003 compared to 35.9% for the nine months of 2002 and 13.3% for the fiscal year 2002. The increase in the period was due to the mix of worldwide income and the receipt of a $5.9 million income tax refund, for which no benefit was previously recorded.

Three months ended June 27, 2003 compared with three months ended June 28, 2002

Net sales

Net sales increased 6.1% to $113.1 million for the three months ended June 27, 2003 from $106.6 million for the same period ended June 28, 2002. The increase was primarily due to $7.5 million of favorable currency fluctuations relating to the strengthening of the Euro and South Korean Won versus the U.S. Dollar during the three months ended June 27, 2003, compared to the same period in the prior fiscal year. In constant dollars, stated at monthly average exchange rates of fiscal year 2002, and excluding the phased out non-core business, sales would have decreased 0.8%. Despite a general seed price increase in all the regions, sales were affected by volume decrease and product mix. This decrease was primarily due to weaker sales in the NAFTA region that were attributable to a reduction of certain carrot and hot pepper sales. Our business is subject to seasonal fluctuations and, therefore, the sales for an interim period are not necessarily indicative of those to be expected in any other interim period or for an entire fiscal year.

Gross Profit

Gross profit increased 9.2% to $71.0 million for the three months ended June 27, 2003 from $65.0 million for the three months ended June 28, 2002. Gross margin increased to 62.8% for the three months ended June 27, 2003 from 61.0% for the three months ended June 28, 2002. The increase was primarily due to general seed price increases in all regions as well as an improved product mix.

Research and Development Expenses

Research and development expenses increased 14.5% to $12.6 million for the three months ended June 27, 2003 from $11.0 million for the three months ended June 28, 2002. The increase was primarily due to the currency fluctuation impact on research and development expenses denominated in the Euro and South Korean Won and general increases from year to year.

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased 6.2% to $46.7 million for the three months ended June 27, 2003 from $44.0 million for the three months ended June 28, 2002. The increase was primarily due to approximately $1.3 million of additional severance expenses, the incurrence of $1.2 million of legal and financial advisory expenses related to the proposed merger and related transaction and the currency fluctuation impact during this quarter. The increase was partially offset by a decrease of $2.9 million of restricted stock award expenses during the same period last year.

Amortization of Intangible Assets

Amortization of intangible assets decreased 5.2% to $4.0 million for the three months ended June 27, 2003 from $4.2 million for the three months ended June 28, 2002. The decrease was primarily due to the effect of latter stages of accelerated amortization of intangible assets related to purchase accounting. The decrease was partially offset by the currency impact from the fluctuation of the South Korean Won on South Korea-based intangible assets.

18


Table of Contents

Gain on Sale of Assets

The gain on sale of assets of $0.4 million for each of the three months ended June 27, 2003 and June 28, 2002 was primarily due to the sale of certain South Korean assets. Moreover, the gain from June 28, 2002 was offset by losses from the sale of certain U.S. assets.

Interest Expense, Net

Interest expense, net, increased 24.3% to $8.8 million for the three months ended June 27, 2003 from $7.1 million for the three months ended June 28, 2002. The increase was primarily due to amortization of increased deferred financing fees and higher interest rates resulting from the amendment of the Company’s syndicated credit facility in January 2003, offset by the effect of lower average debt balances.

Other Non-Operating Income (Expense), Net

Seminis had other non-operating expense, net, including foreign currency gain (loss), net, of $0.8 million for the three months ended June 27, 2003, as compared to other non-operating income, net, of $3.6 million for the three months ended June 28, 2002. Other non-operating expense, net, for the three months ended June 27, 2003 primarily consisted of $0.9 million of non-operating losses from several subsidiaries, offset by an approximate $0.2 million gain from foreign currency resulting from currency fluctuations of a U.S. Dollar denominated loan in the Netherlands. Other non-operating income, net, for the three months ended June 28, 2002 primarily consisted of foreign currency gain of $2.8 million resulting from currency devaluations in South America and a U.S. Dollar denominated loan in the Netherlands, and $0.7 million of non-operating gains from several subsidiaries.

Income Tax Expense

Income tax expense was $1.8 million for the three months ended June 27, 2003, compared to an income tax benefit of $1.5 million for the three months ended June 28, 2002. The year-to date effective tax rate increased to 40.2% for 2003 compared to 35.9% for the nine months of 2002 and 13.3% for the fiscal year 2002. The increase in the quarter was due to the mix of worldwide income and the receipt of a $5.9 million income tax refund, for which no benefit was previously recorded.

Seasonality

The seed business is highly seasonal. Generally, net sales are highest in the second fiscal quarter due to increased demand from Northern Hemisphere growers who plant seed in the early spring. We recorded 33.7% of our fiscal year 2002 net sales during our second fiscal quarter. We have historically operated at a loss during the first and third fiscal quarters due to lower sales during these quarters. Our results in any particular quarter should not be considered indicative of those to be expected for a full year.

Liquidity and Capital Resources

Cash flows from operations

Operating activities utilized $3.6 million in cash flow during the nine months ended June 27, 2003 compared to $2.4 million in cash flow provided during the same period in the prior fiscal year. The operating cash flow of this interim period was negatively impacted by approximately $5.2 million of restructuring fees, $4.5 million of severance and consulting fees paid to an executive, $2.4 million of fees associated with the proposed transaction with Fox Paine and Savia, additional interest incurred due to restructuring of our syndicated credit facility and other additional severance incurred.

Cash flows from investments

Investing activities utilized $0.6 million in cash flow during the nine months ended June 27, 2003 compared to $34.0 million in cash flow utilized in the same period in the prior fiscal year. This reduction was primarily due to $17.6 million of proceeds from the sale of a non-core business and $24.3 million of proceeds from the disposition of assets primarily related to an office building in Seoul, South Korea during the last fiscal year. Capital expenditures remained consistent between the two fiscal periods.

19


Table of Contents

Cash flows from financing

Financing activities utilized $7.8 million and $40.3 million during the nine months ended June 27, 2003 and June 28, 2002, respectively. The reduction was primarily due to principal payment requirements of the syndicated credit facility in the respective periods.

Our total indebtedness as of June 27, 2003 was $274.2 million, of which $216.6 million were borrowings under our existing syndicated credit facility. We had $12.5 million, $10.1 million, $7.5 million and $21.4 million of borrowings by our U.S., Italian, Spanish and South Korean subsidiaries, respectively, and $6.1 million of borrowings by other foreign subsidiaries.

As of September 30, 2000, we were not in compliance with certain covenants of our existing syndicated credit facility, which gave the lenders the right to accelerate payment of all amounts outstanding under the facility. In December 2000, the lenders granted a waiver with respect to these covenants that extended through April 30, 2001, at which time any defaults would once again arise. As we did not expect to be in compliance with our covenants once the waiver expired, all outstanding borrowings under the syndicated credit facility were classified as a current liability as of September 30, 2000. In connection with granting the waivers, the lenders agreed to reschedule principal payments within fiscal year 2001. The lenders also accelerated the final maturity of the term loan and the termination date for the revolving credit commitments to June 30, 2002 from June 30, 2004. We were obligated to deliver a financial plan through September 30, 2002, which detailed cash flow projections on a monthly basis as well as proposed alternatives for the refinancing of the syndicated credit facility or recapitalization of the Company.

On May 31, 2001, our lenders consented to the financial plan that we submitted and agreed to restructure our existing syndicated credit facility. Upon receipt of the amended syndicated credit facility, long-term portions of borrowings were reclassified from current liabilities to long-term debt. Among other things, the amendment extended the final maturity of the syndicated credit facility from the previously agreed on date of June 30, 2002 to December 31, 2002, revised principal payment dates under the term loan, instituted a new grid pricing formula to determine interest on borrowings and revised covenant obligations. Interim principal obligations under the amendment included $16.0 million due in the fourth quarter of fiscal year 2001, $19.0 million, $4.0 million, $31.0 million and $9.0 million due in the first, second, third and fourth quarters of fiscal year 2002, respectively. All remaining amounts were due in the first quarter of fiscal year 2003.

In October 2001, we completed the sale of an office building in Seoul, South Korea, which generated net proceeds of approximately $20.0 million. We used $19.5 million of the proceeds to make the scheduled $19.0 million payment on the syndicated credit facility in October 2001. We also sold one of our non-core businesses in January 2002, which generated additional proceeds of approximately $17.6 million. We used $13.0 million of the proceeds to prepay our existing syndicated credit facility in January 2002 and utilized our operating cash flow to pay the remaining $18.0 million in June 2002.

We met all required principal and interest payments during fiscal years 2002 and 2001 and were in compliance with all of our financial covenants under the amended syndicated credit facility at September 30, 2002. In October 2002, we paid an additional $5.0 million of principal as required by the amended syndicated credit facility; however, as of December 31, 2002, we had not completed a refinancing transaction in order to pay the remaining balance of $224.7 million. The lenders agreed to temporarily extend the term of the syndicated credit facility and in January 2003, a formal amendment was executed. Among other things, the amendment extended the final maturity of the syndicated credit facility from the previously agreed on date of December 31, 2002 to December 31, 2003, revised principal payment dates under the term loan, instituted a new grid pricing formula to determine interest on borrowings and revised covenant obligations. Outstanding interim principal obligations under the amendment included $6.0 million due in the fourth quarter of fiscal year 2003. The remaining outstanding amount totaling $210.6 million will be due in the first quarter of fiscal year 2004. We met all required principal and interest payments during the first six months of fiscal year 2003 and were in compliance with all of our financial covenants at June 27, 2003 under the newly extended amendment. As all remaining amounts under the amended syndicated credit facility are due within one year, the $216.6 million of outstanding borrowings under the syndicated credit facility has been classified as a current liability as of June 27, 2003.

On May 30, 2003, we and/or certain other parties entered into an amended and restated exchange agreement, a contribution agreement, an agreement and plan of merger, a stock purchase agreement and certain other related agreements pursuant to which an acquisition company was formed at the direction of Fox Paine & Company, LLC, a San Francisco based private equity firm, to acquire all of the outstanding shares of the Company’s common stock. Public holders of approximately 15.8 million shares of Seminis common stock will receive cash consideration of $3.78 per share in the merger. Immediately following the merger and related transactions, Fox Paine, its affiliates and co-investors will own approximately 75% of the shares of Seminis common stock outstanding following the completion of the transactions, and the remaining shares will be owned by certain affiliates of Alfonso Romo Garza, Seminis’ and Savia’s current Chairman and Chief Executive Officer, certain creditors of a Savia affiliate and nine members of Seminis and Savia management. Additionally, certain entities affiliated with Mr. Romo will receive co-investment rights to purchase, subject

20


Table of Contents

to certain conditions, up to 34% of the outstanding shares of Seminis common stock following the transactions. Following the merger and related transactions, the Company will be privately held and Seminis common stock will no longer be listed on The Nasdaq National Market. Seminis stockholders representing approximately 85% of the voting power represented by the outstanding shares of Seminis common stock currently entitled to vote have entered into a voting agreement to vote in favor of the merger.

Prior to the consummation of the merger and pursuant to the terms of the amended and restated exchange agreement, Savia will exchange all of its outstanding shares of Seminis Class C preferred stock (including accrued PIK dividends) having a principal value of $120.2 million, additional paid-in capital (including accrued PIK dividends) of $46.7 million and accrued and unpaid dividends for 37.7 million shares of Seminis Class A Common Stock and cash equal to $15.0 million plus interest at a rate of 10.0% per annum from July 1, 2002, less $3.0 million.

Although we have met our obligations and covenant requirements under the amended syndicated credit facility through June 27, 2003, we must successfully execute a refinancing plan prior to December 31, 2003 in order to meet the final maturity of the facility. The consummation of the proposed transactions require the Company’s amended syndicated credit facility to be refinanced. It is anticipated that the proposed transactions would be funded, in part, by financing arranged by the newly-formed acquisition company. There can be no assurances that the merger and related transactions will be consummated. Failure to comply with existing covenants in the amended syndicated credit facility, which would make the facility callable, or our inability to refinance the facility prior to December 31, 2003, could have a material adverse impact on our business, results of operations or financial condition

Seminis’ exposure to foreign currency fluctuations is primarily due to foreign currency gains or losses that occur from intercompany receivables and payables between Seminis and its foreign subsidiaries and from the U.S. dollar denominated loan, originated by SVS Holland, B.V., a foreign subsidiary of Seminis. Seminis does not have any material outstanding hedging contracts as of June 27, 2003.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

     Our market risk disclosures set forth in our Annual Report on Form 10-K for the year ended September 30, 2002 has not changed significantly through the third quarter ended June 27, 2003.

Item 4. Controls and Procedures

(a)   Evaluation of Disclosure Controls and Procedures. The Company’s chief executive officer and VP WW Corporate Comptroller and chief accounting officer have evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-14(c) and 15d-14(c) under the Securities Exchange Act of 1934 as amended the “Exchange Act”) as of a date (the “Evaluation Date”) within 90 days prior to the filing date of this quarterly report. Based on such evaluation, such officers have concluded that, as of the Evaluation Date, the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the U.S. Securities and Exchange Commission. However, in evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgement in evaluating the cost-benefit relationship of possible controls and procedures.
 
(b)   Changes in Internal Controls. Since the Evaluation Date, there have not been any significant changes in the Company’s internal controls or in other factors that could significantly affect these controls during the period covered by this quarterly report.

21


Table of Contents

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

In January 2002, melon growers in Costa Rica notified us that our Dorado melon seeds were infected with watermelon fruit blotch. Growers who purchased the infected Seminis seeds and growers whose crops were infected by the bacteria that spread from crops grown with the infected seeds have claimed damages against us. The claims by those growers who purchased Seminis seeds have been settled for approximately $5.8 million, of which, approximately $2.6 million was recovered under our errors and omissions insurance policy and the remainder of the settlement was paid by the Company by July 2002. The claims by the growers with infected crops total approximately $4.7 million and we believe these claims are covered under our general liability insurance policy. We have finalized a settlement of nearly all of these claims. Our general liability insurance carrier continues to deny coverage, and we are continuing to negotiate with them on this matter. In the event we cannot finalize the settlement with our general liability insurance carrier, we plan to seek all legal remedies and redress available to us against the carrier.

In early 2000, we filed a suit against Dietrich Schmidt, the former president of Seminis and the current president of United Genetics, a competitor of ours, United Genetics and two former Seminis breeders, Ken Owen and Wei Ouyang, for trade secret misappropriation and breach of contract. Schmidt filed a counterclaim for defamation against us. We were unsuccessful on our claims for trade secret misappropriation and breach of contract and Schmidt was successful on his counterclaim, with the court awarding him $1 in nominal damages. The court subsequently awarded Schmidt, Owen and Ouyang their attorneys’ fees. We have appealed certain aspects of the judgment, including the fee award. The appeal is still pending and is not expected to be decided until late 2003.

Between December 17, 2002 and January 31, 2003, five purported class action lawsuits were filed relating to the proposed transaction under which Fox Paine and several Savia-related parties would acquire all of the outstanding shares of Seminis. Four of these actions — Garry Firth v. Alfonso Romo Garza, et al., Civil Action No. 20085, Boris Pozniak v. Alfonso Romo Garza, et al., Civil Action No. 20097, Pablo Herranz v. Seminis, Inc., et al., Civil Action No. 20105 and Haven Capital Management v. Seminis, Inc., et al., Civil Action No. 20140-NC were filed in the Delaware Court of Chancery (New Castle, County), while the fifth, Mark Rosales v. Seminis, Inc., Case No. CIV216255, was filed in California Superior Court (Ventura County). In February 2003, the Firth, Pozniak, Herranz and Haven Capital cases were consolidated into one proceeding entitled In re Seminis, Inc. Shareholders’ Litigation, Consolidated C.A. No. 20140-NC and the Haven Capital complaint was designated as the operative complaint in the consolidated lawsuit. That complaint names as defendant’s Savia, Seminis and Seminis’ directors. The Rosales (California) complaint names as defendants Seminis and its directors. Both the Delaware consolidated action and the Rosales action purport to be brought on behalf of Seminis common stockholders or their successors. Both of these actions-which were brought prior to the public announcement of Seminis entering into the merger agreement-allege that the merger, if consummated, would provide insufficient consideration to Seminis common stockholders and allege that the defendants breached their fiduciary duties in connection with the transaction. The complaints seek a preliminary and permanent injunction to enjoin the transaction and, in the event the transaction is consummated, rescission and damages. No provision for loss has been made in the accompanying consolidated financial statements, as the probability of an unfavorable outcome and the amount of loss, if any, are not determinable at this time.

We are involved from time to time as a defendant in various other lawsuits arising in the normal course of business. We believe that no current claims, individually or in the aggregate, will have a material adverse effect on our business, results of operations or financial condition.

Item 6. Exhibits and Reports on Form 8-K

(a)   Exhibits
 
    See exhibits index.
 
(b)   Reports on Form 8-K

On April 15, 2003, the Company filed a Current Report on Form 8-K reporting under Item 5 thereof that Savia has noticed its shareholders for a meeting to be held at the end of the month to authorize the necessary actions to be taken by Savia, assuming that the transactions contemplated by the letter of intent between Savia and Fox Paine & Company, LLC are consummated.

On May 2, 2003, the Company filed a Current Report on Form 8-K (a) furnishing under Item 12 thereof the preliminary results of its operations for the quarter ended March 28, 2003 and (b) filing as an exhibit under Item 7 thereof the related press release.

22


Table of Contents

On May 16, 2003, the Company filed a Current Report on Form 8-K (a) furnishing under Item 12 thereof the unaudited results of its operations for the three and six month periods ending March 28, 2003 and (b) filing as an exhibit under Item 7 thereof the related press release.

On June 5, 2003, the Company filed a Current Report on Form 8-K (a) reporting under Item 5 thereof that the Company entered into a definitive agreement and plan of merger, dated as of May 30, 2003, with Seminis Acquisition LLC and Seminis Merger Corp., both affiliates of Savia, and related agreements and (b) filing as exhibits under Item 7 thereof a copy of the merger agreement and other related agreements.

Exhibit Index

     
Exhibit    
Number   Description

 
(a) 1   Form of Underwriting Agreement
     
(c) 2   Merger Agreement by and between Seminis, Inc., an Illinois corporation and Seminis, Inc., a Delaware corporation
     
(c) 3.1   Certificate of Incorporation
     
(c) 3.2   Certificate of Designations of Class A Mandatorily Redeemable Preferred Stock and Class B Mandatorily Redeemable Preferred Stock of Seminis, Inc.
     
(c) 3.3   Certificate of Designations of Class C Redeemable Preferred Stock of Seminis, Inc.
     
(c) 3.4   By-Laws
     
(t) 10.1   Agreement and Plan of Merger by and among Seminis, Inc., Seminis Acquisition LLC and Seminis Merger Corp., dated as of May 30, 2003, incorporated herein by reference to the Form 8-K filed by Seminis, Inc. on June 5, 2003.
     
(t) 10.2   Stock Purchase Agreement by and among Fox Paine Seminis Holdings., LLC Banca Afirme, SA., Institución de Banca Multiple, Afirme Grupo Financiero, as Trustee, Under the Irrevocable Administration and Payment Trust Number 167-5 (Fideicomiso Irrevocable de Administración y Pago Número 167-5), Seminis Acquisition LLC and Seminis Merger Corp., dated as of May 30, 2003, incorporated herein by reference to the Form 8-K filed by Seminis, Inc. on June 5, 2003.
     
(t) 10.3   Voting Agreement by and among Savia, S.A. de C.V., Banca Afirme, S. A., Institución de Banca Multiple, Afirme Grupo Financiero, as Trustee, under the Irrevocable Administration and Payment Trust Number 167-5 (Fideicomiso Irrevocable de Administración y Pago Número 16705), Conjunto Administrativo Integral, S.A. de C.V., Emprima S.A. de C.V., Park Financial Group, Ltd (BVI), Seminis Acquisition LLC, Alfonso Romo Garza and Fox Paine Seminis Holdings, LLC, dated as of May 30, 2003, incorporated herein by reference to the Form 8-K filed by Seminis, Inc. on June 5, 2003.
     
(t) 10.4   Amended and Restated Exchange Agreement by and between Seminis, Inc. and Savia, S.A. de C.V., dated as of May 30, 2003, incorporated herein by reference to the Form 8-K filed by Seminis, Inc. on June 5, 2003.
     
(t) 10.5   Contribution Agreement by and among Seminis Acquisition LLC, Savia, S.A. de C.V., Banca Afirme, S.A., Institución de Banca Multiple, Afirme Grupo Financiero, as Trustee, under the Irrevocable Administration and Payment Trust Number 167-5 (Fideicomiso Irrevocable de Administración y Pago Número 167-5), Conjunto Administrativo Integral, S.A. de C.V., Desarrollo Consolidado de Negocios, S.A. de C.V., Emprima, S.A. de C.V., Park Financial Group, Ltd (BVI), Alfonso Romo Garza and Certain Members of Seminis and Savia Management, dated as of May 30, 2003, incorporated herein by reference to the Form 8-K filed by Seminis, Inc. on June 5, 2003.
     
(t) 99.1/99.2   Certification pursuant to section 906 of the Sarbanes Oxley Act of 2002

23


Table of Contents

     
Exhibit    
Number   Description

 
(a)   Incorporated by reference to Seminis’ Form S-1 filed on February 11, 1999.
     
(b)   Incorporated by reference to Seminis’ Amendment No. 2 to Form S-1 filed on May 27, 1999.
     
(c)   Incorporated by reference to Seminis’ Amendment No. 3 to Form S-1 filed on June 21, 1999.
     
(d)   Filed with the June 30, 2000 Form 10-Q.
     
(e)   Filed with the September 30, 2000 Form 10-K.
     
(f)   Filed with the December 30, 2000 Form 10-Q.
     
(g)   Filed with the March 30, 2001 Form 10-Q.
     
(h)   Filed with the June 29, 2001 Form 10-Q.
     
(i)   Filed with the September 30, 2001 Form 10-K.
     
(j)   Filed with the March 29, 2002 Form 10-Q.
     
(k)   Filed with the September 30, 2002 Form 10-K.
     
(l)   Filed with the December 27, 2002 Form 10-Q.
     
(m)-(s)   Filed with the March 28, 2003 Form 10-Q.
     
(t)   Filed with the June 27, 2003 Form 10-Q.

24


Table of Contents

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

     
Date: August 11, 2003   SEMINIS, INC.
     
    By /s/ Alfonso Romo Garza
   
    Alfonso Romo Garza
    Chief Executive Officer
    (Principal Executive Officer)
     
    By /s/ Gaspar Alvarez Martinez
   
    Gaspar Alvarez Martinez
    VP WW Corporate Comptroller &
    Chief Accounting Officer
    (Principal Financial and Accounting Officer)

25


Table of Contents

Certification

I, Alfonso Romo Garza, certify that:

1.   I have reviewed this quarterly report on Form 10-Q of Seminis, Inc.;
 
2.   Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
 
3.   Based on my knowledge, the financial statements and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;
 
4.   The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

  a)   designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
 
  b)   evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and
 
  c)   presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

5.   The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

  a)   all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and
 
  b)   any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

6.   The registrant’s other certifying officers and I have indicated in this quarterly report whether there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

Date: August 11, 2003

   
  /s/ Alfonso Romo Garza
 
  Alfonso Romo Garza
  Chief Executive Officer

26


Table of Contents

Certification

I, Gaspar Alvarez Martinez, certify that:

1.   I have reviewed this quarterly report on Form 10-Q of Seminis, Inc.;
 
2.   Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
 
3.   Based on my knowledge, the financial statements and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;
 
4.   The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

  a)   designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
 
  b)   evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and
 
  c)   presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

5.   The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

  a)   all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and
 
  b)   any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

6.   The registrant’s other certifying officers and I have indicated in this quarterly report whether there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

Date: August 11, 2003

   
  /s/ Gaspar Alvarez Martinez
 
  Gaspar Alvarez Martinez
  VP WW Corporate Comptroller &
  Chief Accounting Officer

27